Question 1

What are the potential benefits of trying ITCA 650 compared to sitagliptin?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate ITCA 650 Compared to Sitagliptin for the Treatment of Type 2 Diabetes clinical trial (NCT01455909). Contact the study team or your healthcare provider for specific answers.

Question 2

How might this trial affect my current diabetes management plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate ITCA 650 Compared to Sitagliptin for the Treatment of Type 2 Diabetes clinical trial (NCT01455909). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of for both ITCA 650 and sitagliptin?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate ITCA 650 Compared to Sitagliptin for the Treatment of Type 2 Diabetes clinical trial (NCT01455909). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to visit the clinic if I participate in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate ITCA 650 Compared to Sitagliptin for the Treatment of Type 2 Diabetes clinical trial (NCT01455909). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate ITCA 650 Compared to Sitagliptin for the Treatment of Type 2 Diabetes clinical trial (NCT01455909). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate ITCA 650 Compared to Sitagliptin for the Treatment of Type 2 Diabetes clinical trial (NCT01455909). Contact the study team or your healthcare provider for specific answers.

What this study is about